Data systems update, data integration, and computational applications to support drug discovery and therapeutics development
Active Awarded Last action
- Contract number
- 75N91020F00015
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,410,146
Award facts
- Contract value 100% obligated
- $8,410,146.00 Current and potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $250,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,760,437 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,399,709 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 25, 2020, with a ceiling value of $8.41 million for data systems updates, data integration, and computational applications supporting drug discovery and therapeutics development through March 31, 2027.
Place of performance is Frederick, Maryland. The order is priced on a cost-plus-fixed-fee basis with no set-aside designation.
Service Contract Inventory reporting shows actual government-invoiced labor across four fiscal years. FY2024 (the most recent reported year) reflects 7.1 FTEs and 14,827 contractor hours, with a derived blended hourly rate of $87.79. One subcontractor accounted for 72 percent of contractor hours in FY2024. The program footprint has grown substantially since FY2021 (1.0 FTE, 2,180 hours, $301 thousand invoiced), peaking at FY2023 levels before contracting slightly in FY2024; the derived hourly rate has declined across the period.
Quick answers
Who was awarded contract 75N91020F00015?
75N91020F00015 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2020.
How much is contract 75N91020F00015 worth?
The government has obligated $8,410,146 on 75N91020F00015.
Is contract 75N91020F00015 an order under another contract?
Yes. 75N91020F00015 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00015 competed?
The extent of competition for 75N91020F00015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award